This post was updated Aug. 6 at 3:25 p.m.
The rate of new COVID-19 cases is increasing in Los Angeles County, largely because of the spread of the delta variant among unvaccinated populations.

This post was updated June 27 at 9:11 p.m.
Creating a more inclusive environment for LGBTQ+ students in STEM is one of Rob Ulrich’s goals as a queer biogeochemistry doctoral student.

UCLA students showed their resilience through the COVID-19 pandemic by serving their community through research, work and volunteering.
The UCLA campus closed in March 2020, and instruction remains remote with reduced on-campus housing for students.

A UCLA-led research team developed a potential treatment for a rare, life-threatening immune disease in children using genetically modified stem cells.
Children with adenosine deaminase deficiency, which often causes severe combined immunodeficiency, are born without a functional immune system.

Genetically engineered stem cells could be used to create a longer lasting and more efficient gene therapy to treat – and potentially cure – HIV infections, a UCLA study found.

Artificial intelligence expert Kai-Fu Lee emphasized the importance of an international exchange of ideas in AI technology at a presentation Monday as part of a weeklong virtual UCLA conference.

UCLA researchers are leading a Centers for Disease Control and Prevention-funded study to investigate the effectiveness of COVID-19 vaccinations among health care workers.
The CDC allocated more than $11 million to four programs conducting studies evaluating the effectiveness of COVID-19 vaccines, including Preventing Emerging Infections Through Vaccine Effectiveness Testing, a study led by researchers from the David Geffen School of Medicine.

Rising ocean temperatures and ocean acidification could have negative cumulative effects that slow the growth of tropical coral reefs, according to a UCLA-led study published in early January.

UCLA researchers can transfer mitochondria from one cell into another reprogrammable cell at a high rate using a newly developed technology called MitoPunch, according to UCLA research published in late December.

Chronic wounds are a problem in the United States, said Philip Scumpia, an assistant professor of dermatology at UCLA.
Millions of chronic wounds do not heal properly each year, costing the health care system billions of dollars annually, he said.